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Abstract
Aims and Objectives: To investigate the expression of CD10 and osteopontin in dentigerous cyst and
ameloblastoma and to correlate their expression with neoplastic potentiality of dentigerous cyst and local invasion
and risk of local recurrence in ameloblastoma.
Methods: CD10 and osteopontin expression was studied by means of immunohistochemistry in 9 cases of
dentigerous cysts (DC) and 17 cases of ameloblastoma. There were 7 unicystic ameloblastoma (UCA) and 10
multicystic ameloblastoma (MCA). Positive cases were included in the statistical analysis, carried on the tabulated
data using the Open Office Spreadsheet 3.2.1 under Linux operating system. Analysis of variance and correlation
studies were performed using “R” under Linux operating system (R Development Core Team (2010). Tukey post-hoc
test was also performed as a pair-wise test. The significant level was set at 0.05.
Results: High CD10 and osteopontin expression was observed in UCA and MCA, and low CD10 and osteopontin
expression was observed in DC. Significant correlation was seen between CD10 and osteopontin expression and
neoplastic potentiality of DC and local invasion and risk of recurrences in ameloblastoma.
Conclusions: In DC, high CD10 and osteopontin expression may indicate the neoplastic potentiality of certain
areas. In UCA & MCA, high CD10 and osteopontin expression may identify areas with locally invasive behavior and
high risk of recurrence.
Background
Dentigerous cyst (DC) is the most common develop-
mental cyst in the oral cavity, accounting for 20% of the
developmental cysts of the jaws, and is almost always
associated with the crown of a tooth attached to the
cemento-enamel junction. It is believed to originate
from the accumulation of fluid between the reduced
enamel epithelium and the tooth crown, thus expanding
the follicle beyond the 3 mm normal diameter and
hence is usually associated with impacted or un-erupted
teeth [1].
Ameloblastoma is an uncommon benign, locally
aggressive odontogenic neoplasm that accounts for
approximately 10% of all tumors that arise in the mand-
ible and maxilla [2]. Although the etiology is unknown,
ameloblastoma is believed to develop from various
sources of odontogenic epithelia, including dental folli-
cular lining epithelium [3]. Ameloblastoma is classified
as central or peripheral. Central ameloblastomas are
classified as multicystic/solid (MCA) or unicystic (UCA)
[4]. Multicystic/solid ameloblastomas tend to be more
aggressive and have a higher likelihood of recurrence
after surgery compared with unicystic and peripheral
ameloblastomas [5].
CD 10 cell surface glycoprotein was initially identified
as a 100 KDa tumor associated antigen (common acute
lymphoblastic leukemia antigen, CALLA) on human
acute lymphoblastic leukemias and other lymphoid
malignancies with an immature phenotype [6]. CD10 is
expressed on the surface of a variety of normal and neo-
plastic hematopoietic and lymphoid cells, including lym-
phoid precursor cells, germinal center B lymphocytes
and some epithelial cells [7].
The specialized effects of the action of CD10/Neutral
Endopeptidase (NEP) are attributable to the substrates
present in different tissues, at points of contact between
cells and extracellular matrix or between adjacent cells;
surface CD10 would then regulate the local concentra-
tions of specific peptides [8]. CD10 may also play an
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tic transformation, and tumor progression [9]. Recent
works suggested that CD10 expression in cancer cells
could have a role both in apoptosis and proliferation
[10], while CD10 expression in intratumoral stromal
cells may also contribute to tumor progression [11].
High CD10 expression was associated with poor prog-
nosis in various tumors like breast carcinoma [11],
malignant melanoma [12], cutaneous basal cell and
squamous cell carcinoma [13] and oral squamous cell
carcinoma [14].
Meanwhile, osteopontin (OPN) was identified inde-
pendently, together with bone sialoprotein (BSP), as a
major sialoprotein in the extracellular matrix of bone
and the 2 proteins were initially called bone sialoprotein
(BSP I) and bone sialoprotein II (BSP II), respectively
[15]. Constitutive expression of OPN exists in several
cell types but induced expression has been detected in
T lymphocytes, epidermal cells, bone cells, macrophages,
and tumor cells in remodeling processes such as inflam-
mation, ischemia-reperfusion, bone resorption, and
tumor progression [16].
OPN has been shown to be multifunctional, with
activities in cell migration, cell survival, inhibition of cal-
cification, regulation of immune cell function, and con-
trol of tumor cell phenotype [17]. Binding of OPN to
tumor cell membrane receptor CD44v6 can enhance
tumor cell motility [18] and increase the immune adap-
tation of OPN-expressing cells [19]. OPN can also trig-
ger integrin-mediated signal transduction, which, in
turn, leads to osteoclast activation [20]. Ligation of OPN
with integrin a5b3 on vascular endothelial cells induces
neovascularization by up-regulating endothelial cell
migration, survival, and lumen formation during angio-
genesis [21].
High OPN expression was associated with poor prog-
nosis in various tumors like prostate carcinoma [22],
breast carcinoma [23] and cutaneous squamous cell car-
cinoma [24]. Concerning ameloblastoma, high OPN
expression was reported in both unicystic and multicys-
tic ameloblastoma [25].
The present study was conducted to investigate the
expression of CD10 and osteopontin in dentigerous cyst
and ameloblastoma and to correlate their expression
with neoplastic potentiality of dentigerous cyst and local
invasion and risk of local recurrence in ameloblastoma.
Methods
1. Materials
Twenty-six formalin fixed paraffin-embedded archival
blocks of dentigerous cyst and ameloblastoma were
obtained from the archives of the oral pathology depart-
ment, Ain Shams University and National Cancer Insti-
tute, Cairo University. Data of the archival paraffin
blocks included the histopathological diagnosis of each
case as well as history of recurrence in cases diagnosed
as multicystic ameloblastoma. Each case was then coded
and patient’s name was not shown for ethical reasons.
Nine cases were diagnosed as dentigerous cyst, seven
cases were diagnosed as unicystic ameloblastoma, and
ten cases were diagnosed as multicystic ameloblastoma.
To confirm the diagnosis 5 µm thick sections were cut
and mounted on glass slides, sections were stained with
haematoxylin and eosin stain and examined by light
microscope.
2. Immunohistochemical procedures
For all specimens 4 µm sections were cut and mounted
on positively charged glass slides. Sections were deparaf-
finized with xylene and rehydrated in graded ethyl alco-
hol, and sections were immersed in citrate buffer
solution of pH 4.8 and were put in the microwave oven
before staining procedures. For immunostaining a uni-
versal kit (Lab Vision) was used, peroxidase anti- peroxi-
dase method of immunostaining using the streptavidin-
biotin system was carried out, and 3% hydrogen perox-
ide was applied to the sections to block the endogenous
peroxidase activity. Sections were immunostained using
the concentrated primary monoclonal antibody (clone
56C6) against CD10 (Thermo Fisher Scientific Labora-
tories, Ltd, United Kingdom), and monoclonal lyophi-
lized antibody (clone OP3N) against OPN
(Visionbiosystems Novocastra™ Laboratories, Ltd, Uni-
ted Kingdom) and then incubated overnight at room
temperature after rinsing with PBS (phosphate buffered
saline) solution. Sections were then covered by the link
antibody followed by the streptavidin labeling antibody;
after rinsing with PBS, DAB chromogen was applied to
the sections followed by counter stain, then sections
were dehydrated in graded alcohol, cleared in xylene
and mounted.
3. Assessment
For each positive section, four microscopic fields show-
ing highest immunopositivity were selected and photo-
micrographs were captured at a magnification of 20X.
This was performed using a video camera (C5060,
Olympus, Japan) which was mounted on a light micro-
scope (BX60, Olympus, Japan). Images were then trans-
ferred to the computer system for analysis. All the steps
for immunohistochemical evaluation were carried out
using image analysis software (Image J, 1.41a, NIH,
USA).
4. Statistical Analysis
Positive cases were included in the statistical analysis,
carried on the tabulated data using Open Office Spread-
sheet 3.2.1 under Linux operating system. Analysis of
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“R” under Linux operating system (R Development Core
Team (2010). Analysis Of Variance (ANOVA) test was
used to test the significance of mean differences within
dentigerous cyst and ameloblastoma. Post Hoc test was
used when ANOVA test revealed a significant differ-
ence, to assess the significance of differences within den-
tigerous cyst and ameloblastoma.
The results were considered significant when P value
≤ 0.05. Welch Two Sample t-test was done to compare
the expression of CD10 or OPN in primary versus
recurrent ameloblastoma. The statistical tests performed
included Pearson’s correlation analysis to test correla-
tion between CD10 and OPN expression in dentigerous
cyst and ameloblastoma.
Results
A) Immunohistochemical Results
Positive CD10 and OPN staining was found in all cases
examined in the present study. The positive cases showed
a homogenous and brownish immunostaining. For CD10:
In DC, cytoplasmic & membranous immunoreactivity
was seen mainly in the superficial layers of the epithelial
lining (Figure 1). In the intraluminal UCA, most of the
central cells of epithelial strands showed membranous
reaction, while few of these cells showed both membra-
nous and cytoplasmic reaction (Figure 2). On the other
hand, in the mural cases, the epithelial cells facing the
cystic cavity showed both membranous and cytoplasmic
reaction, while basal and suprabasal cells were immuno-
negative. The stellate reticulum like cells in the mural
strands showed cytoplasmic reaction (Figure 3). In MCA,
the neoplastic epithelial cells showed cytoplasmic and
membranous immunopositivity (Figure 4). For OPN: In
DC, cytoplasmic immunoreactivity was seen in epithelial
cells, inflammatory cells and endothelial cells of blood
vessels (Figure 5). In intraluminal UCA, the tumor cells
and inflammatory cells in the stroma showed cytoplasmic
reaction (Figure 6). In mural UCA, cytoplasmic immuno-
positivity in ameloblast like cells & few stellate reticulum
like cells was seen resulting in a peritumoral positive
reaction (Figure 7). In MCA, few stellate reticulum like
cells showed cytoplasmic reaction, while most of the
ameloblast like cells showed cytoplasmic reaction.
Figure 1 Photomicrograph of DC showing cytoplasmic &
membranous immunopositivity of superficial epithelial cells
(Anti-CD10.Original magnification x40).
Figure 2 Photomicrograph of intraluminal UCA showing
cytoplasmic & membranous reaction of central cells of
epithelial strands (red arrow) (Anti-CD10. Original
magnification x40).
Figure 3 Photomicrograph of mural UCA showing cytoplasmic
& membranous immunopositivity of stellate reticulum like cells
while basal & suprabasal cells are immunonegative (Anti-CD10.
Original magnification x40).
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rounding the tumor (Figure 8).
B) Statistical Results
Tukey pair wise test revealed a statistically significant dif-
ference in the expression of CD10 in DC & MCA, and in
UCA & MCA (p values less than 0.001). On the other
hand, there was no statistically significant difference in
the expression of CD10 in UCA & DC (Table 1).
The Tukey pair-wise test showed a statistically signifi-
cant difference in the expression of OPN in MCA &
DC, and in UCA & DC (p values less than 0.001). On
the other hand, there was no statistically significant dif-
ference in the expression of OPN in UCA & MCA (p
values more than 0.001) (Table 2). Statistical results of
Welch Two Sample t-test revealed a statistically insignif-
icant difference between CD10 or OPN mean area frac-
tion in recurrent versus primary MCA (Tables 3 and 4).
Pearson’s correlation test showed a significant strong
direct positive correlation between CD10 and OPN
immunopositivity in either dentigerous cyst or amelo-
blastoma (r value = 0.622, P-value < 0,001) (Figure 9).
Figure 4 Photomicrograph of plexiform MCA showing
cytoplasmic immunopositivty of neoplastic epithelial strands
(Anti-CD10.Original magnification x40).
Figure 5 Photomicrograph of DC showing cytoplasmic
immunoreactivity in epithelial cells, inflammatory cells and in
endothelial cells of blood vessels (Anti-OPN. Original
magnification x40).
Figure 6 Photomicrograph of intraluminal plexiform variant of
UCA showing cytoplasmic immunopositivity in tumor cells
forming strands (Anti-OPN. Original magnification x40).
Figure 7 Photomicrograph of mural follicular variant of UCA
showing cytoplasmic immunopositivity in ameloblast like cells
& few stellate reticulum like cells. Note the peritumoral
positive reaction (Anti-OPN. Original magnification x40).
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Dentigerous cyst (DC) is the most common develop-
mental cyst in the oral cavity, accounting for 20% of the
developmental cysts of the jaws, and is almost always
associated with the crown of a tooth attached to the
cemento-enamel junction [1]. Ameloblastoma is an
uncommon benign, locally aggressive odontogenic neo-
plasm that accounts for approximately 10% of all tumors
that arise in the mandible and maxilla [2]. Ameloblas-
toma is classified as central or peripheral. Central ame-
loblastomas are classified as multicystic/solid (MCA) or
unicystic (UCA) [4].
The immunohistochemical results of the present study
showed that cytoplasmic & membranous CD10 immu-
noreactivity was seen mainly in the superficial layers of
the epithelial lining of DC. These results were found to
be in accordance to that reported by Liapatas et al [26]
who reported CD10 expression in periapical granulomas
and cysts. In UCA, the results of the present study
revealed that the immunohistochemical expression of
CD10 in the mural cases was different from that noted
in the intraluminal cases. In the intraluminal cases,
CD10 was expressed in the stellate reticulum like cells
and this expression was mainly membranous. On the
other hand in mural cases, the epithelial cells facing the
cystic cavity showed membranous and cytoplasmic
immunoreactivity of CD10, while the stellate reticulum
like cells in the mural strands showed mainly a cytoplas-
mic reaction. These results were found to be consistent
with the results of other studies such as that of Grana-
d o se ta l .[ 2 7 ]a n dA i a da n dH a n o u t[ 1 3 ]w h e r et h e
tumor cells in these studies showed mainly cytoplasmic
expression of CD10. This difference in the expression of
CD10 in the intraluminal and mural variants of UCA
might explain the variable behavior of these two var-
iants. This finding was in agreement with the argument
of Rosenstein et al [28] who suggested that the luminal
and intraluminal variants of UCA were non aggressive
and could be treated by enucleation whereas the mural
variant should be treated more aggressively and con-
cluded that since most of the recurrent cases of amelo-
blastoma were of the mural type, connective tissue
invasion can be considered an important microscopic
sign. Linear with these data was that reported by Gard-
ner [29] who stated that once mural invasion occurred,
the UCA at this stage would act as classic intraosseous
ameloblastoma and has to be treated as such. In MCA,
the neoplastic epithelial cells showed cytoplasmic and
membranous immunopositivity. This might be explained
by the argument of Ogawa et al [30] who stated that
CD10 was associated with the differentiation and growth
of neoplastic cells.
Statistical analysis of the present study revealed that
the CD10 mean area fraction of immunopositivity
increased from DC to UCA and MCA. This could be
explained by the different biological properties of CD10
which could facilitate the neoplastic transformation of
DC and the locally invasive behavior of ameloblastoma.
T h eh i g h l ya g g r e s s i v ea n dl o c ally invasive behavior of
Figure 8 Photomicrograph of follicular variant of MCA showing
cytoplasmic immunopositivity of both ameloblast like cells &
stellate reticulum like cells. Note the immunonegativity of
most of the ameloblast like cells lining the large-sized follicles
and peritumoral reaction (AntiOPN. Original magnification
x40).
Table 1 Descriptive statistics (CD10)
Lesions Mean Std.Deviation Std.Error
DC 3.033 2.343 36
MCA 9.995 4.915 40
UCA 4.925 2.851 28
Tukey pair-wise test for CD10.
Lesion diff Lower upper p-value
MCA-DC 6.962 4.838 9.085 0.000
UCA-DC 1.892 -0.438 4.21 0.154
UCA-MCA -5.070 -7.348 -2.792 0.000
* The mean difference is significant at the 0.05 level
Table 2 Descriptive statistics (OPN)
lesions Mean Std.Deviation Std.Error
DC 8.9 3.3 36
MCA 18.2 7.1 40
UCA 17.0 3.8 28
Tukey pair-wise test for OPN
lesion diff lower upper P-value
MCA-DC 9.31 6.29 12.33 0.000
UCA-DC 8.14 4.83 11.45 0.000
UCA-MCA -1.17 -4.41 2.07 0.781
* The mean difference is significant at the 0.05 level
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cant difference in CD10 expression when comparing
M C Aw i t hD Ca n dU C Aa st h eC D 1 0c o u l df a c i l i t a t e
this aggressive behavior.
These results were consistent with the results of Iezzi
et al [31] who showed that the mean area fraction of
stromal CD10 immunopositivity of MCA was higher
than that of UCA and peripheral ameloblastoma.
Although the mean area fraction of CD10 in UCA was
higher than that of DC, this difference was found to be
statistically insignificant.
The immunohistochemical results of the present study
showed that OPN immunoreactivity was seen in both
epithelium of DC together with underlying connective
tissue. However, these results were not consistent with
that reported by Wang and Liu [20] who found OPN
immunopostivity in odontogenic keratocysts but not in
DC. This OPN expression pattern in the epithelial lining
of DC might be an early indicator of neoplastic transfor-
mation of DC into UCA. This is supported by the fact
the induced expression of OPN has been detected in
epidermal cells in remodeling processes as the tumor
progresses [16]. Chang et al [24] further supported this
argument and stated that OPN expression in both
benign and malignant tumors suggested its association
with the process of tumorgenesis.
The immunohistochemical results of the present study
also revealed a different distribution pattern of OPN
among different variants of UCA. In the intraluminal
cases, OPN immunoreactivity was noted in neoplastic
epithelial cells with no peritumoral stromal reaction.
This expression pattern was similar to that noted in DC.
This finding might explain the favorable behavior of
these two subtypes as being non aggressive variants of
UCA [28]. In the mural cases, the OPN expression was
noted in neoplastic epithelial cells as well as peritumoral
stromal tissue. This difference in OPN localization in
this particular variant when compared to luminal and
intraluminal UCA might explain the difference in the
biological behavior of these variants. This explanation is
supported by the argument of Wang and Liu [25] who
stated that the tumor cell produced OPN could facilitate
the tumor cell adhesion and migration in the bone
resulting in tumor invasion and spread. So this weak
expression of OPN in luminal and intraluminal sub-
types, when compared to the mural subtype, might
explain why these two subtypes have a favorable prog-
nosis and less invasive behavior than that of the mural
subtype.
In MCA, the results of the present study revealed that
in both follicular and plexiform ameloblastoma, cyto-
plasmic OPN immunoreactivity was observed in amelo-
blast like cells, with cytoplasmic localization in few
stellate reticulum like cells. Peritumoral reaction was
also noted in the stroma surrounding the tumor. This
distribution pattern was found to be consistent with
that reported by Wang and Liu [25].This expression pat-
tern of OPN could be explained by the argument of
Wang and Liu [25] who stated that OPN protein is
probably synthesized and secreted by stellate reticulum
like cells, picked up by ameloblast like cells and released
into the peritumor nest stromal tissue (transcytosis in
ameloblast like cells) in ameloblastoma. They also added
the possibility that a small amount of OPN is produced
by ameloblast like cells also could not be ruled out [25].
Since OPN can enhance tumor cell migration, inva-
sion and spread, activate osteoclasts, and protect cells
from immune mediated cytotoxicity, the elevated
expression of OPN in ameloblastoma tumor cells and
peritumor nest connective tissue of ameloblastoma, can,
at least, partially explain why MCA have the locally
invasive behavior and high osteolytic ability [25]. It was
reported that OPN expression was associated with
recurrence in prostate cancer [22]. Also, odontogenic
keratocyst, which is known for its high rate of recur-
rence, showed strong OPN immunostaining in both its
Table 3 Welch Two Sample t-test (CD10)
Dependent Variable MCA Mean AF 95% Confidence Interval df P value
Lower Bound Upper Bound
CD10 Mean Area Fraction Primary MCA 4.6536 2.1695 3.3140 39 0.8178
Recurrent MCA 4.2000
* The mean difference is significant at the 0.05 level
Table 4 Welch Two Sample t-test (OPN)
Dependent Variable MCA Mean AF 95% Confidence Interval df P value
Lower Bound Upper Bound
OPN Mean Area Fraction Primary MCA 12.4393 3.6277 5.5415 39 0.2741
Recurrent MCA 16.0667
* The mean difference is significant at the 0.05 level
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So, the elevated expression of OPN in ameloblastoma
might explain the high recurrence rate of this lesion.
In different lesions included in the present study, OPN
expression in inflammatory cells could be explained by
the fact induced expression has been detected in T lym-
phocytes, macrophages, and in remodeling processes
such as inflammation, ischemia-reperfusion, bone
resorption, and tumor progression [16]. Also, detected
OPN expression along the walls of blood vessels might
indicate the possible role of OPN in neovascularization.
This could be explained by the binding properties of
OPN, where the ligation of OPN with integrin a3b5o n
vascular endothelial cells induces neovascularization by
upregulating endothelial cell migration, survival and
lumen formation during angiogenesis. This might
explain the OPN immunoreactivity in endothelial cells
noted in the present study [16,21]. These angiogenic
properties of OPN would increase the rate of tumor
growth. The statistical analysis of the present study
revealed that the mean area fraction of OPN immuno-
positivity of UCA and MCA was higher than that of
DC. The difference in the mean area fraction of OPN in
UCA (mural variant) and MCA when compared to DC
might explain the locally invasive behavior of these two
variants. This difference was found to be statistically sig-
n i f i c a n t .I nU C A&M C A ,t h es t atistically insignificant
difference of OPN expression in these two groups could
be due to that most of the UCA studied were of the
mural type, as it was reported that the behavior of the
mural type is similar to that of the classic intraosseous
MCA [28]. Statistical results of the present study
revealed a statistically insignificant difference of either
C D 1 0o rO P Nm e a na r e af r a c t i o nw h e nc o m p a r i n g
recurrent versus non recurrent MCA. This might be
due to inconsistent data gathered from a small sample
size of the present study. Thus, further studies utilizing
more recurrent cases of MCA are highly recommended.
A Pearson’s correlation study showed that there was a
strong significant positive correlation between the levels
of CD10 and OPN expression (R value = 0.622). This
correlation was proven to be statistically significant (P
value < 0.001). This could be explained by the different
biological properties of CD10 regarding neoplastic trans-
formation and tumor progression [9]. OPN enhance-
ment of tumor cell migration, invasion and spread [32],
activation of osteoclast [20], and protection of cells from
immune mediated cytoxicity [19] might also add to
understand this positive association between the two
markers. So these two markers could function in a
synergistic way to facilitate the neoplastic transformation
of DC and the locally invasive behavior of
ameloblastoma.
Conclusions
Based upon the results of the present study, it could be
concluded that, in DC, high CD10 and osteopontin
expression might predict the neoplastic potentiality of
the epithelial lining of this cyst. Also, in UCA & MCA,
high CD10 and osteopontin expression might be a use-
ful tool to identify areas with locally invasive behavior
and high risk of recurrence.
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